Tag Archives: over

Over 100,000 Released Documents Expose COVID Origin Fraud

In a March 31, 2022, investigative report,1 Vanity Fair contributor Katherine Eban reviewed the contents of more than 100,000 EcoHealth Alliance documents, including meeting minutes and internal emails and reports, most of which predate the COVID-19 pandemic, showing a disturbing reality of “murky grant agreements, flimsy NIH oversight and pursuit of government grants by pitching… Read More »

Supreme Court will hear case over Trump admin’s 340B drug program cuts to hospitals

Dive Brief: The Supreme Court has agreed to hear a case involving the Trump administration’s cuts of Medicare Part B reimbursement for drugs that hospitals obtain under the 340B program. The case pivots on whether CMS has the authority to make payment cuts under the outpatient prospective payment system. The justices are expected to hear… Read More »

Astellas’ Xtandi nabs leg up over Johnson & Johnson’s Erleada with NICE prostate cancer win in UK

During the pandemic, Astellas’ oral prostate cancer drug Xtandi scored an interim nod in England as a “COVID friendly” way to treat men at home instead of in hospitals. With the pandemic easing there, cost watchdogs are backing the drug’s use for thousands of patients, offering the company an edge over its rival Johnson & Johnson. The National… Read More »

AstraZeneca vaccine: Will UK suspend AstraZeneca vaccine over blood clot fears?

However, the European Medicines Agency (EMA) said on Thursday there is no indication the vaccine has caused these symptoms. The EMA said in a statement: “There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. “The vaccine’s benefits continue to outweigh its risks and… Read More »